9B17
Crystal Structure of human Tryptophan 2,3-dioxygenase in complex with PAN1 inhibitor
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | NSLS-II BEAMLINE 17-ID-2 |
| Synchrotron site | NSLS-II |
| Beamline | 17-ID-2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2024-02-10 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97934 |
| Spacegroup name | P 21 21 2 |
| Unit cell lengths | 143.610, 154.014, 88.580 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 34.290 - 2.650 |
| Rwork | 0.190 |
| R-free | 0.23440 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.006 |
| RMSD bond angle | 1.402 |
| Data reduction software | autoPROC (1.0.5 20211020) |
| Data scaling software | STARANISO (2.3.79) |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.8.0425) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 34.290 | 34.290 | 3.006 |
| High resolution limit [Å] | 2.648 | 8.511 | 2.648 |
| Rmerge | 0.107 | 0.029 | 0.879 |
| Rmeas | 0.121 | 0.033 | 0.981 |
| Rpim | 0.054 | 0.015 | 0.432 |
| Total number of observations | 174706 | 8477 | 9213 |
| Number of reflections | 36145 | 1807 | 1808 |
| <I/σ(I)> | 10.89 | 34.33 | 1.84 |
| Completeness [%] | 92.7 | 96 | 62.2 |
| Completeness (spherical) [%] | 62.4 | 96.0 | 10.0 |
| Completeness (ellipsoidal) [%] | 92.7 | 96.0 | 62.2 |
| Redundancy | 4.83 | 4.69 | 5.1 |
| CC(1/2) | 0.998 | 0.999 | 0.611 |
| Anomalous completeness (spherical) | 60.6 | 96.6 | 9.5 |
| Anomalous completeness | 91.5 | 96.6 | 61.9 |
| Anomalous redundancy | 2.6 | 2.7 | 2.7 |
| CC(ano) | -0.058 | -0.159 | 0.002 |
| |DANO|/σ(DANO) | 0.8 | 0.7 | 0.8 |
| Diffraction limits | Principal axes of ellipsoid fitted to diffraction cut-off surface |
| 2.647 Å | 1.000, 1.000, 1.000 |
| 3.153 Å | 0.000, 0.000, 0.000 |
| 3.348 Å | 0.000, 0.000, 0.000 |
| Criteria used in determination of diffraction limits | local <I/sigmaI> ≥ 1.2 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | MICROBATCH | 298 | 50 mM Sodium Citrate pH 5.6, 2.0% Tacsimate pH 5.0, 5.0% PEG 3350 |






